Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab

Single-agent immune checkpoint inhibitor therapy in advanced non-small cell lung cancer can significantly prolong progression-free and overall survival when compared with cytotoxic chemotherapy. Here, we report a case of newly diagnosed adenocarcinoma of the lung with a solitary brain metastasis and...

Descripción completa

Detalles Bibliográficos
Autores principales: Saltman, David L., Nielsen, Tyler J., Salina, Davide, Hout, David R., McMahon, Frank B., Valev, Boris R., Huk, Michael, Chandra, Pranil K., Spille, Jeremy, Seitz, Robert S., Schweitzer, Brock L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058789/
https://www.ncbi.nlm.nih.gov/pubmed/33953802
http://dx.doi.org/10.1177/17588359211010156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058789/
https://www.ncbi.nlm.nih.gov/pubmed/33953802
http://dx.doi.org/10.1177/17588359211010156

Ejemplares similares